U.S., Dec. 6 -- ClinicalTrials.gov registry received information related to the study (NCT07265570) titled 'Study Evaluating ISM5411 Administered Orally to Subjects With Active Ulcerative Colitis' on Nov. 14.
Brief Summary: This is a multicenter, randomized, double-blind, placebo-controlled study to evaluate the safety, tolerability, pharmacokinetics and clinical efficacy of ISM5411 in adult patients with active ulcerative colitis.
Study Start Date: Dec. 10
Study Type: INTERVENTIONAL
Condition:
Ulcerative Colitis
Intervention:
DRUG: ISM5411 tablets
Dosage Form: Tablet; Frequency of administration: Orally QD.
DRUG: ISM5411 tablets
Dosage Form: Tablet; Frequency of administration: Orally QD.
DRUG: ISM5411 tablets
Dosage Form: Tabl...